180 related articles for article (PubMed ID: 23981264)
21. [Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)].
Cosset JM; Gomme S; Peiffert D; Guerif S; Labib A; Hannoun-Lévi JM; Martin P; Quétin P; Nguyen TD; Flam T; Thiounn N; Henni M; Rosenwald JC; Housset M; Pontvert D; Asselain B; Chauveinc L
Cancer Radiother; 2007 Jun; 11(4):206-13. PubMed ID: 17604675
[TBL] [Abstract][Full Text] [Related]
22. [Contracts including performance and management of uncertainty].
Duru G; Garassus P; Auray JP
Ann Pharm Fr; 2013 Sep; 71(5):338-45. PubMed ID: 24075704
[TBL] [Abstract][Full Text] [Related]
23. [Immunization: process of elaborating guidelines and their evolution in France].
Floret D
Ann Pharm Fr; 2009 May; 67(3):219-23. PubMed ID: 19446673
[TBL] [Abstract][Full Text] [Related]
24. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
25. Reform legislation: potential implications for physicians.
Weil TP
Pa Med; 1993 May; 96(5):30-2. PubMed ID: 8510964
[No Abstract] [Full Text] [Related]
26. Relative added value: what are the tools to evaluate it?
Le Jeunne C; Woronoff-Lemsi MC; David N; de Sahb R;
Therapie; 2008; 63(2):113-7, 107-11. PubMed ID: 18561884
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the medical value of a drug. A necessity for the Transparency Commission].
Avouac B
Therapie; 1992; 47(1):9-16. PubMed ID: 1523604
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of generic drug supply in France].
Taboulet F; Haramburu F; Latry P
Rev Epidemiol Sante Publique; 2003 Sep; 51(4):415-25. PubMed ID: 13679734
[TBL] [Abstract][Full Text] [Related]
29. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
30. Senate committee approves bill to require drug discounts for clinics.
Wash Memo Alan Guttmacher Inst; 1992 Feb; (4):1-2. PubMed ID: 12284785
[TBL] [Abstract][Full Text] [Related]
31. Scientific evaluation and pricing of medical devices and associated procedures in France.
Gilard M; Debroucker F; Dubray C; ; Allioux Y; Aper E; Barat-Leonhardt V; Brami M; Carbonneil C; Chartier-Kastler E; Coqueblin C; Fare S; Giri I; Goehrs JM; Levesque K; Maugendre P; Parquin F; Sales JP; Szwarcensztein K
Therapie; 2013; 68(4):193-208. PubMed ID: 23981256
[TBL] [Abstract][Full Text] [Related]
32. Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies.
Xoxi E; Di Bidino R; Leone S; Aiello A; Prada M
Front Med Technol; 2022; 4():917151. PubMed ID: 36134249
[TBL] [Abstract][Full Text] [Related]
33. [French Health Authority (HAS) Guidance: the post-registration studies on health technologies (drugs, medical devices and instruments): principles and methods].
Stamenkovic S; Solesse A; Zanetti L; Zagury P; Vray M;
Therapie; 2012; 67(5):409-21. PubMed ID: 23241250
[TBL] [Abstract][Full Text] [Related]
34. National Authority for Health: France.
Rochaix L; Xerri B
Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
[TBL] [Abstract][Full Text] [Related]
35. [The transparency committee of the French National Authority for Health].
Lengliné E
Bull Cancer; 2024 Feb; 111(2):228-234. PubMed ID: 38176970
[TBL] [Abstract][Full Text] [Related]
36. Social security: a program and policy history.
Martin PP; Weaver DA
Soc Secur Bull; 2005; 66(1):1-15. PubMed ID: 16295313
[TBL] [Abstract][Full Text] [Related]
37. [The ANMCO (National Association of Hospital Cardiologists) in a changing health care system. Consensus development of the Organizing Symposium of the XXXI National Congress of Cardiology--ANMCO; Florence, May 21, 2000].
Ital Heart J Suppl; 2000 Dec; 1(12):1533-44. PubMed ID: 11221582
[TBL] [Abstract][Full Text] [Related]
38. Public procurement of health technologies in Greece in an era of economic crisis.
Kastanioti C; Kontodimopoulos N; Stasinopoulos D; Kapetaneas N; Polyzos N
Health Policy; 2013 Jan; 109(1):7-13. PubMed ID: 22502936
[TBL] [Abstract][Full Text] [Related]
39. Assessment of economic effectiveness in treatment of neuropathic pain and refractory angina pectoris using spinal cord stimulation.
Harat A; Sokal P; Zieliński P; Harat M; Rusicka T; Herbowski L
Adv Clin Exp Med; 2012; 21(5):653-63. PubMed ID: 23356203
[TBL] [Abstract][Full Text] [Related]
40. Social Security's special minimum benefit.
Olsen KA; Hoffmeyer D
Soc Secur Bull; 2001-2002; 64(2):1-15. PubMed ID: 12428507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
